Neoadjuvant Chemotherapy in Elderly Patients With Upper Tract Urothelial Cancer: Oncologic Outcomes From a Multicenter Study.
暂无分享,去创建一个
V. Margulis | S. Shariat | P. Karakiewicz | C. Fankhauser | D. D’andrea | M. Moschini | H. Fajkovic | M. Abufaraj | B. Pradère | V. Schuettfort | E. Xylinas | P. Nyirády | M. Bandini | K. Mori | S. Katayama | P. Rajwa | N. Grossmann | E. Laukhtina | F. Quhal | C. Lonati
[1] Y. Lotan,et al. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma , 2020, BJU international.
[2] Steven L. Chang,et al. Neoadjuvant and Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A 2020 Systematic Review and Meta-analysis, and Future Perspectives on Systemic Therapy. , 2020, European urology.
[3] A. Masson-Lecomte,et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update. , 2020, European urology.
[4] S. Shariat,et al. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis , 2020, International Journal of Clinical Oncology.
[5] J. Donovan,et al. Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial , 2020, The Lancet.
[6] S. Shariat,et al. Management of bladder cancer in older patients: Position paper of a SIOG Task Force. , 2020, Journal of geriatric oncology.
[7] V. Margulis,et al. Efficacy of Preoperative Chemotherapy in High-Risk Upper Tract Urothelial Carcinoma (UTUC). , 2020, The Journal of urology.
[8] M. Babjuk,et al. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC) , 2017, World Journal of Urology.
[9] C. Dinney,et al. Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy , 2016, World Journal of Urology.
[10] Yair Lotan,et al. Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer. , 2015, European urology.
[11] R. Thompson,et al. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma , 2014, BJU international.
[12] C. Stief,et al. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. , 2014, European urology.
[13] T. Clozel,et al. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro‐ureterectomy , 2013, BJU international.
[14] F. Montorsi,et al. Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis. , 2012, European urology.
[15] Y. Lotan,et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. , 2012, European urology.
[16] K. Bensalah,et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. , 2012, European urology.
[17] J. Coleman,et al. Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract urothelial carcinoma , 2012, BJU international.
[18] Y. Lotan,et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. , 2011, European urology.
[19] G. Sonpavde,et al. Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] A. Vickers,et al. Tumor markers in prostate cancer I: Blood-based markers , 2011, Acta oncologica.
[21] S. Shariat,et al. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy , 2011, World Journal of Urology.
[22] M. Stifelman,et al. Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy. , 2010, European urology.
[23] J. Coleman,et al. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. , 2010, European urology.
[24] R. Millikan,et al. The Effectiveness of Off-Protocol Adjuvant Chemotherapy for Patients with Urothelial Carcinoma of the Urinary Bladder , 2010, Clinical Cancer Research.
[25] B. Lane,et al. Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy , 2010, Cancer.
[26] K. Bensalah,et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. , 2010, European urology.
[27] B. Bochner,et al. The effect of age and gender on bladder cancer: a critical review of the literature , 2010, BJU international.
[28] F. Montorsi,et al. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients. , 2009, European journal of cancer.
[29] K. Bensalah,et al. Advanced patient age is associated with inferior cancer‐specific survival after radical nephroureterectomy , 2009, BJU international.
[30] M. Milowsky,et al. Bladder cancer in the elderly. , 2009, Urologic oncology.
[31] K. Bensalah,et al. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi‐institutional analysis of 1363 patients , 2009, BJU international.
[32] F. Saad,et al. Clinicians are poor raters of life‐expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer , 2007, BJU international.
[33] Y. Lotan,et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. , 2007, European urology.
[34] L. Repetto,et al. Greater risks of chemotherapy toxicity in elderly patients with cancer. , 2003, The journal of supportive oncology.
[35] T. Clozel,et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. , 2014, European urology.